Angel E. Valdes-Loza
3 Pasteur Street
Warsaw, MZ 02093, Poland
Warsaw, MZ 02093, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Erk3 deletion drives oxidative adaptations in skeletal muscle.
Journal: Molecular metabolism
Published: November 28, 2025
Triazolo[4,5-d]pyrimidin-5-amines based ERK3 inhibitors fail to demonstrate selective effects on adipocyte function.
Journal: Archives of biochemistry and biophysics
Published: July 25, 2023
Platelet-derived lipids promote insulin secretion of pancreatic β cells.
Journal: EMBO molecular medicine
Published: September 08, 2022
Targeting ERK3/MK5 complex for treatment of obesity and diabetes.
Journal: Biochemical and biophysical research communications
Published: April 05, 2022
Protein Kinase D2 drives chylomicron-mediated lipid transport in the intestine and promotes obesity.
Protein Kinase D2 drives chylomicron-mediated lipid transport in the intestine and promotes obesity.
Journal: EMBO molecular medicine
Published: October 06, 2020
A phosphoproteomic approach reveals that PKD3 controls PKA-mediated glucose and tyrosine metabolism.
A phosphoproteomic approach reveals that PKD3 controls PKA-mediated glucose and tyrosine metabolism.
Journal: Life science alliance
Published: July 28, 2020
Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review.
Journal: Lipids in health and disease
Published: March 18, 2020
Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity.
Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity.
Journal: The EMBO journal
Published: February 06, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026